Immuno Oncology Assays Market - Global Industry Analysis
Immuno Oncology Assays Market by Product (Consumables and Software), by Assay (Cell Migration & Invasion, Cell Proliferation, Immune Cell Killing, Phagocytosis, and Others), by Technology (PCR, Immunoassay, NGS, Flow Cytometry, and Others), by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Cancers), and by Application (Clinical Diagnostics and Research Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 27-May-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-3963
Status : Published
Global immuno oncology assays market expected to generate around USD 6.63 billion by 2025, at a CAGR of around 12.9% between 2019 and 2025. The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb).